Published: April 6, 2026
Last updated: April 6, 2026
Author: Doko MD Education Team
Clinical review: Doko MD Clinical Review Team
Many patients assume that qualifying for a continuous glucose monitor is simply a matter of getting a prescription. In reality, insurance approval usually depends on several moving parts: your diabetes history, your current treatment plan, the insurer's criteria, the clinician's documentation, and whether the request goes through the correct supplier or pharmacy workflow.
What Insurers Usually Look At
Most plans want more than a general statement that CGM would be helpful. They typically want to understand why the device is medically appropriate for the patient right now. That often means reviewing the diagnosis, current medications, glucose patterns, risk of high or low blood sugar, and whether the requested device fits the plan's rules.
- Diagnosis: Documentation showing that the patient has diabetes.
- Current treatment: Details such as insulin use, other medications, and current monitoring routine.
- Medical necessity: Clear explanation of why CGM is appropriate for the patient's management needs.
- Recent visit note: A current clinician note is often needed to support the request.
- Correct channel: Some plans route CGM through pharmacy benefits, others through DME suppliers.
Do You Have to Use Insulin?
Not always. Some patients qualify because they use insulin, but that is not the only possible path. Coverage can also depend on recurrent glucose problems, safety concerns, or plan-specific criteria. The exact standard differs across Medicare, Medicare Advantage, Medicaid, and private insurance.
That means it is risky to rely on a blanket statement like "insurance only covers CGM if you use insulin." In many cases the better question is whether the submitted documentation fits the insurer's current standard.
What Documents Usually Matter Most
From a practical standpoint, many delays come from missing or incomplete documentation rather than outright ineligibility. A strong request usually includes a recent chart note, a prescription, and clear medical-necessity language that explains how CGM supports safer or more effective diabetes management.
Why Requests Get Delayed
Most CGM approval delays fall into one of a few common categories:
- The chart note is too old or does not match the request.
- The prior authorization form is incomplete.
- The insurer needs more specific medical-necessity wording.
- The request was sent through the wrong supplier or billing channel.
- The plan only covers certain devices or preferred brands.
What Patients Can Do Before Starting the Process
- Confirm which insurance plan is active and whether the question is going through pharmacy or DME.
- Ask for a recent diabetes follow-up note if you have not had one recently.
- Know which device you are requesting, if your plan limits brand choice.
- Be ready to explain whether the issue is high variability, hypoglycemia, insulin dosing, or another management problem.
- Keep track of whether the delay is happening with the clinic, the supplier, or the insurer.
How Doko MD Helps
Patients often lose time because each part of the process points somewhere else. A clinic may say the supplier has the order, the supplier may say the insurer needs more information, and the patient may not know what is actually missing. Doko MD helps clarify the path and reduce that back-and-forth.
Related Pages
- Diabetes Supplies Through Insurance
- Diabetes Insurance Coverage Guide
- Does Medicare Cover CGM for Type 2 Diabetes in 2026?
Frequently Asked Questions
Not always. Some plans may cover CGM for patients who are not using insulin, but the exact criteria depend on the insurer and the documentation submitted.
Insurers often want a recent clinician note, diagnosis details, proof of medical necessity, current treatment information, and a prescription for the device.
Requests are often delayed because of missing chart notes, incomplete prior authorization forms, unclear medical necessity language, or supplier network issues.